185. Laboratory findings in hypertensive disorders of pregnancy
/M.P.FizGerald [et al.] // J. Natl. Mad. Assn. - 1996. - Vol. 88, № 12. - P. 794-
798.
186. Lack of thrombopoietin potentiation of platelet collagen activation in the
first trimester is associatedwith preeclampsia / R.C. Carroll [et al.] // Thromb. Res.
-2005.-Vol. 116,№ 1.-P . 51-54.
187. Lorentzen B. Plasma lipids and vascular dysfunction in preeclampsia
/B.Lorentzen, T. Henriksen // Sem. Reprod. Endocrinol. - 1998. - Vol. 16. - P. 33-
39.
188. Lymphocyte populations and subpopulations in peripheral blood of preg
nant women with pre-eclampsia [Article in Bulgarian] / E. Dimitrakova-
Dzhambazova [et al.] // Akush. Ginekol. (Sofiia). - 2005. - Vol. 44, № 1.—P. 40-
44.
189. Nitrotyrosine residues in placenta: Evidence ofperoxynitrite formation and
action / L. Myatt [et al.] // Hypertension. - 1996. - Vol. 28. - P. 488-493.
190. Oxidative stress, diet, and the etiology of preeclampsia / T.O. Scholl [et
al.] // Am. J. Clin. Nutr. - 2005. - Vol. 81,№ 6. - P. 1390-1396.
191. Page E.W. The relation between hydatid moles, relative ischemia of the
gravid uterus, and the placental origin of preeclampsia / E.W. Page // Am. J. Ob-
stet. Gynaecol. - 1939. - Vol. 37. - P. 291-293.
192. Preeclampsia— eclampsia. Pathogenesis, diagnosis and treatment /C.Song
[et al.] // Br. J. Obstet. Gynecol. - 1998. -№ 74. - P. 1065-1071.
193. Preeclampsia is associated with global cerebral hemodynamic changes
/S.Riskin-Mashiah [et al.] // J. Soc. Gynecol. Investig. - 2005. - Vol. 12, № 4. -
P. 253-256.
194. Prostacyclin, Thromboxane A2, and the Effect ofLow-Dose ASA in Preg
nancies at High Risk for Hypertensive Disorders / M. Vainio [et al.] // Obstet. Gy
necol. Surv. - 2005. - Vol. 60,№ 5. - P. 281-282.
195. Protein measurement with the Folin phenol reagent / O.H. Lowery [et al.]
//J. Biol. Chem.-1951.-Vol. 193,№ l.-P . 265-275.
140
